Hepatobiliary X-ray
Protocols
X-ray Hydatid cyst:

CXR-1
CXR-1: Chest X-ray PA view showing a huge mass with clear margin occupying the left upper and midzones,
obscuring the left upper border of heart. Another mass in left lower zone.
Differential diagnoses:
- Q: What are the presentations of hydatid cyst of lung?
- A: As follows:
- • Asymptomatic.
- • Sometimes there may be cough, breathlessness, secondary infection (causing lung abscess).
- • The cyst may rupture into the tracheobronchial tree or pleural cavity. Rupture may be associated with the
- sudden onset of cough and fever. If the contents of the cyst are expelled into the airway, expectoration of a clear salty
- or peppery-tasting fluid containing fragments of hydatid membrane and scolices may occur.
Magnetic resonance cholangiopancreatography (MRCP)
What is MRCP?
- A: Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive imaging technique to
- visualize intrahepatic and extrahepatic biliary tree and pancreatic ductal system.
It can provide the diagnostic range equivalent to ERCP and so it can replace ERCP in high-risk patients to avoid significant morbidity.
Fig:Cholelithiasis with choledocholithiasis.
X-RAY-A: This is an MRCP showing multiple gallstones as well as multiple common bile duct stones.
Diagnosis: Cholelithiasis with choledocholithiasis.

Fig-B: Biliary stricture.
X-RAY-B: This is an MRCP showing:
Diagnosis: Biliary stricture.
Fig-C: Cholangiocarcinoma.
X-RAY-C: This is an MRCP showing dilatation of the intrahepatic bile ducts with disconnection between the left- and right-sided ducts and the common duct. The distal CBD and pancreatic duct appear normal.
Diagnosis: Cholangiocarcinoma.

Fig-D: Periampullary tumour.
X-RAY-D: This is an MRCP showing intrahepatic bile ducts and CBD are grossly dilated with distal narrowing. Pancreatic duct appears normal.
Diagnosis: Periampullary tumour.

- Fig-E:Calcific pancreatitis.
X-RAY-E: This is an MRCP showing dilatation of the main pancreatic duct. There is a stone in the proximal pancreatic duct.
Endoscopic retrograde cholangiopancreatography (ERCP):

Fig-A:Normal ERCP.
ERCR finding fig-A: This is an ERCP showing normal pancreatic duct and normal intrahepatic and extrahepatic biliary tree and gallbladder.
Diagnosis: Normal ERCP.

Fig-B; Choledocholithiasis.
ERCR finding fig-B:
This is an ERCP showing dilatation of common bile duct and intrahepatic biliary tree. Multiple translucent shadows within the common bile duct.
Diagnosis: Choledocholithiasis (stone in common bile duct).
Fig-C:Pancreatic calculi.
ERCP finding fig-C:This is an ERCP showing dilatation of pancreatic duct. Multiple translucent shadows within the pancreatic duct.
Diagnosis: Pancreatic calculi.

Fig-F:Roundworm in common bile duct.
ERCP finding fig-F:
This is an ERCP showing dilatation of common bile duct and intrahepatic biliary tree. A linear translucent shadow within the common bile duct.
Diagnosis: Roundworm (ascariasis) in common bile duct.
- Q: How to treat such a case?
- A: The worm is removed during ERCP. Antihelminthic drug should be given (such as albendazole or mebendazole or pyrantel pamoate).

- Fig-G: ERCP (choledochal cyst).
aERCP finding fig-G:
This is an ERCP showing cyst with dilatation of extrahepatic and intrahepatic biliary tree.
Diagnosis: Choledochal cyst.

- Fig -H: ERCP (cholangiocarcinoma).
sERCP Finding Fig-H: This is an ERCP showing irregularity with stricture at the lower part of common bile duct.
Diagnosis: Cholangiocarcinoma.
Diagnosis: Carcinoma of pancreas.
Q: What other investigations can be done?
• Liver function test may be done.
Q: What is primary sclerosing cholangitis?
A: Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by fibrosing inflammatory
destruction of intrahepatic and extrahepatic bile ducts that leads to gradual obliteration of biliary tree and
ultimately biliary cirrhosis, portal hypertension and hepatic failure.
Q: What are the clinical features of primary sclerosing cholangitis?
A: Common in males. Seventy-five per cent is associated with inflammatory bowel disease, commonly ulcerative colitis.
Cholangiocarcinoma may occur in 10%–30% of cases.
• May be asymptomatic. Diagnosed incidentally with abnormal liver function test, mainly high
serum alkaline phosphatase. Also during ultrasonography.
• Features of inflammatory bowel disease.
• Anorexia, nausea, vomiting, fatigue, malaise, weight loss.
• Pain in right hypochondrium.
• Pruritus.
• Features of malabsorption, cholestasis (stool is clay- or muddy-coloured).
Signs are:
• Scratch marks on whole body.
• In advanced cases: Stigmata of CLD may be present.
Q: What investigations should be done in primary sclerosing cholangitis?
• Liver function tests (high alkaline phosphatase is common).
• Ultrasonography of hepatobiliary system.
• P-ANCA is high in 60% of cases.
• MRCP (it is the key investigation).
• ERCP may be done in some cases (if therapeutic intervention is indicated).
• P-ANCA: Positive in 60%–80% of cases in ulcerative colitis.
• ANA and anti-smooth muscle antibody may be positive.
Q: How to treat primary sclerosing cholangitis?
• Symptomatic: Cholestyramine for pruritus, ursodeoxycholic acid, fat-soluble vitamin supplementation.
• Immunosuppressive drugs, such as prednisolone, azathioprine, cyclosporin, tacrolimus, MTX. Anti-TNF agents,
such as etanercept or infliximab, may be given.
• In some cases, endoscopic biliary intervention with balloon dilatation and stenting may improve biochemistry and symptoms.
• Orthotopic livEr transplantation is the definitive treatment. The only curative treatment is liver transplantation.


